Glucose-conjugated glutenin nanoparticles for selective targeting and delivery of camptothecin into breast cancer cells.
暂无分享,去创建一个
Sureshbabu Ram Kumar Pandian | A. S. K. Kumar | P. Pavadai | T. Panneerselvam | Selvaraj Kunjiappan | V. Deepak | Sivakumar Vellaichamy | K. Sundar | Raja Rajeswari Rajeshkumar | Shanmugampillai Jeyarajaguru Kabilan | Anbu Jeyaraman
[1] D. Koundal,et al. Global Increase in Breast Cancer Incidence: Risk Factors and Preventive Measures , 2022, BioMed research international.
[2] K. Yadav,et al. Breast cancer in India: Present scenario and the challenges ahead , 2022, World journal of clinical oncology.
[3] T. Gathani,et al. Understanding breast cancer as a global health concern , 2021, The British journal of radiology.
[4] Z. Shariatinia. Big family of nano- and microscale drug delivery systems ranging from inorganic materials to polymeric and stimuli-responsive carriers as well as drug-conjugates , 2021 .
[5] A. Krześlak,et al. Contemporary Perspectives on the Warburg Effect Inhibition in Cancer Therapy , 2021, Cancer control : journal of the Moffitt Cancer Center.
[6] Akshay Joshi,et al. Polymeric Micelles Coated with Hybrid Nanovesicles Enhance the Therapeutic Potential of the Reversible Topoisomerase Inhibitor Camptothecin in a Mouse Model. , 2020, Acta biomaterialia.
[7] Nicholas A. Peppas,et al. Engineering precision nanoparticles for drug delivery , 2020, Nature reviews. Drug discovery.
[8] M. Pedraza-Escalona,et al. Glycosylated Nanoparticles for Cancer-Targeted Drug Delivery , 2020, Frontiers in Oncology.
[9] A. Qattan. Novel miRNA Targets and Therapies in the Triple-Negative Breast Cancer Microenvironment: An Emerging Hope for a Challenging Disease , 2020, International journal of molecular sciences.
[10] S. Govindaraj,et al. Surface receptor‐mediated targeted drug delivery systems for enhanced cancer treatment: A state‐of‐the‐art review , 2020, Drug development research.
[11] Sureshbabu Ram Kumar Pandian,et al. Formulation and evaluation of rutin-loaded solid lipid nanoparticles for the treatment of brain tumor , 2020, Naunyn-Schmiedeberg's Archives of Pharmacology.
[12] Zehuan Liao,et al. Smart nanocarriers for cancer treatment: Clinical impact and safety , 2020 .
[13] Mohammed M Mehanna,et al. Updated but not outdated "Gliadin": A plant protein in advanced pharmaceutical nanotechnologies. , 2020, International journal of pharmaceutics.
[14] M. Sharifi-Rad,et al. Lifestyle, Oxidative Stress, and Antioxidants: Back and Forth in the Pathophysiology of Chronic Diseases , 2020, Frontiers in Physiology.
[15] A. Fazeli,et al. Zeta Potential of Extracellular Vesicles: Toward Understanding the Attributes that Determine Colloidal Stability , 2020, ACS omega.
[16] M. Arumugam,et al. Bioactive and thermostable sulphated polysaccharide from Sargassum swartzii with drug delivery applications. , 2020, International journal of biological macromolecules.
[17] Sureshbabu Ram Kumar Pandian,et al. Formulation and characterization of folate receptor-targeted PEGylated liposome encapsulating bioactive compounds from Kappaphycus alvarezii for cancer therapy , 2020, 3 Biotech.
[18] B. Salehi,et al. Plant-Derived Bioactives and Oxidative Stress-Related Disorders: A Key Trend towards Healthy Aging and Longevity Promotion , 2020, Applied Sciences.
[19] S. Jacob,et al. Emerging role of nanosuspensions in drug delivery systems , 2020, Biomaterials Research.
[20] P. Ranjekar,et al. Phytochemicals in Cancer Treatment: From Preclinical Studies to Clinical Practice , 2020, Frontiers in Pharmacology.
[21] S. Govindaraj,et al. Design, in silico modelling and functionality theory of folate-receptor-targeted myricetin-loaded bovine serum albumin nanoparticle formulation for cancer treatment , 2019, Nanotechnology.
[22] S. P. Srinivas,et al. Current trends and challenges in cancer management and therapy using designer nanomaterials , 2019, Nano Convergence.
[23] Chao Qiu,et al. Preparation and characterization of redox-sensitive glutenin nanoparticles. , 2019, International journal of biological macromolecules.
[24] Jingyan Tian,et al. Nanoliposomal formulation encapsulating celecoxib and genistein inhibiting COX-2 pathway and Glut-1 receptors to prevent prostate cancer cell proliferation. , 2019, Cancer letters.
[25] J. Natarajan,et al. Modeling a pH-sensitive Zein-co-acrylic acid hybrid hydrogels loaded 5-fluorouracil and rutin for enhanced anticancer efficacy by oral delivery , 2019, 3 Biotech.
[26] A. Misra,et al. Combinatorial nanocarriers against drug resistance in hematological cancers: Opportunities and emerging strategies , 2019, Journal of controlled release : official journal of the Controlled Release Society.
[27] Leonardo Fernandes Fraceto,et al. Nano based drug delivery systems: recent developments and future prospects , 2018, Journal of Nanobiotechnology.
[28] Z. Dai,et al. Ultrasound Triggered Conversion of Porphyrin/Camptothecin-Fluoroxyuridine Triad Microbubbles into Nanoparticles Overcomes Multidrug Resistance in Colorectal Cancer. , 2018, ACS nano.
[29] P. Mulvaney,et al. Colloidal Stability of Apolar Nanoparticles: The Role of Particle Size and Ligand Shell Structure. , 2018, ACS nano.
[30] Miryoung Kim,et al. Daunorubicin and Cytarabine Liposome in Newly Diagnosed Therapy-Related Acute Myeloid Leukemia (AML) or AML With Myelodysplasia-Related Changes , 2018, The Annals of pharmacotherapy.
[31] Samreen I. Ahmed,et al. Principles of cancer treatment by chemotherapy , 2018, Surgery (Oxford).
[32] A. Nel,et al. Nanotechnology Strategies To Advance Outcomes in Clinical Cancer Care. , 2017, ACS nano.
[33] Wei Zhang,et al. Camptothecin-based nanodrug delivery systems , 2017, Cancer biology & medicine.
[34] M. Akram,et al. Awareness and current knowledge of breast cancer , 2017, Biological Research.
[35] Quan Li,et al. Shape dependent cytotoxicity of PLGA-PEG nanoparticles on human cells , 2017, Scientific Reports.
[36] A. Elaissari,et al. Protein-based nanoparticles: From preparation to encapsulation of active molecules. , 2017, International journal of pharmaceutics.
[37] C. Bhattacharjee,et al. Nanotechnology and nanocarrier-based approaches on treatment of degenerative diseases , 2017, International Nano Letters.
[38] Jiang Yuan,et al. Preparation and characterization of DOX loaded keratin nanoparticles for pH/GSH dual responsive release. , 2017, Materials science & engineering. C, Materials for biological applications.
[39] K. Burgess,et al. Small Molecules for Active Targeting in Cancer , 2016, Medicinal research reviews.
[40] A. Otto. Warburg effect(s)—a biographical sketch of Otto Warburg and his impacts on tumor metabolism , 2016, Cancer & metabolism.
[41] N. Reddy,et al. Development of wheat glutenin nanoparticles and their biodistribution in mice. , 2015, Journal of biomedical materials research. Part A.
[42] R. Kaushik,et al. Isolation, characterization of wheat gluten and its regeneration properties , 2015, Journal of Food Science and Technology.
[43] Xiguang Chen,et al. Glucose-conjugated chitosan nanoparticles for targeted drug delivery and their specific interaction with tumor cells , 2014, Frontiers of Materials Science.
[44] K. Buschard,et al. Dietary gluten and the development of type 1 diabetes , 2014, Diabetologia.
[45] Xi-jun Wang,et al. Plant-derived natural products as leads to antitumor drugs , 2014 .
[46] B. Mishra,et al. Mannose-conjugated chitosan nanoparticles loaded with rifampicin for the treatment of visceral leishmaniasis. , 2014, Carbohydrate polymers.
[47] John C Kraft,et al. Emerging research and clinical development trends of liposome and lipid nanoparticle drug delivery systems. , 2014, Journal of pharmaceutical sciences.
[48] Baorui Liu,et al. Facile preparation of paclitaxel loaded silk fibroin nanoparticles for enhanced antitumor efficacy by locoregional drug delivery. , 2013, ACS applied materials & interfaces.
[49] J. Ramirez-Vick,et al. Evaluation of the cytotoxic effect of camptothecin solid lipid nanoparticles on MCF7 cells , 2013, Drug delivery.
[50] E. Mittendorf,et al. Cancer immunotherapies, their safety and toxicity , 2013, Expert opinion on drug safety.
[51] Radhakrishna Sureshkumar,et al. Effects of nanoparticle charge and shape anisotropy on translocation through cell membranes. , 2012, Langmuir : the ACS journal of surfaces and colloids.
[52] Anjan Nan,et al. Combination Drug Delivery Approaches in Metastatic Breast Cancer , 2012, Journal of drug delivery.
[53] Chandana Mohanty,et al. Receptor mediated tumor targeting: an emerging approach for cancer therapy. , 2011, Current drug delivery.
[54] V. Venditto,et al. Cancer therapies utilizing the camptothecins: a review of the in vivo literature. , 2010, Molecular pharmaceutics.
[55] M. Ozkan,et al. A surface-charge study on cellular-uptake behavior of F3-peptide-conjugated iron oxide nanoparticles. , 2009, Small.
[56] E. Miele,et al. Albumin-bound formulation of paclitaxel (Abraxane® ABI-007) in the treatment of breast cancer , 2009, International journal of nanomedicine.
[57] R. Wang,et al. Functional properties of a new low-molecular-weight glutenin subunit gene from a bread wheat cultivar , 2006, Theoretical and Applied Genetics.
[58] H. Klok,et al. Advanced drug delivery devices via self-assembly of amphiphilic block copolymers. , 2001, Advanced drug delivery reviews.
[59] H. M. Geller,et al. Induction of neuronal apoptosis by camptothecin, an inhibitor of DNA topoisomerase-I: evidence for cell cycle-independent toxicity , 1996, The Journal of cell biology.
[60] M. López-Meyer,et al. Sites of accumulation of the antitumor alkaloid camptothecin in Camptotheca acuminata. , 1994, Planta medica.
[61] A. Norin,et al. A novel ligand in lymphocyte-mediated cytotoxicity: expression of the beta subunit of H+ transporting ATP synthase on the surface of tumor cell lines , 1994, The Journal of experimental medicine.
[62] T. Burke,et al. The structural basis of camptothecin interactions with human serum albumin: impact on drug stability. , 1994, Journal of medicinal chemistry.
[63] O. Warburg,et al. THE METABOLISM OF TUMORS IN THE BODY , 1927, The Journal of general physiology.